logo

For the Inventor, By the Inventor

Uji, Japan

Nobuto Koyama

This inventor holds 37 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent, primarily in Retroviral Gene Transfer. Top assignees: Takara Shuzo Co., Inc., Takara Bio Inc., Osaka University. Active years: 1995-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nobuto Koyama. Retrieved from https://idiyas.com/inventor/nobuto-koyama

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 37 

% Patents Active = 64.9


Average Co-Inventor Count = 5.7

ph-index = 5

Forward Citations = 121(Granted Patents)


Location History:

  • Kyoto-fu, JP (1998)
  • Uji-shi, Kyoto-fu, JP (1999)
  • Uji-shi, Kyoto JP (2002)
  • Uji-shi, Kyoto, JP (2005)
  • Kyoto, JP (2005 - 2008)
  • Uji, JP (1995 - 2011)
  • Otsu, JP (2000 - 2015)

Company Filing History:

goldMedal24 out of 190 
 
Takara Shuzo Co., Inc.
 patents
silverMedal10 out of 150 
 
Takara Bio Inc.
 patents
bronzeMedal1 out of 1,041 
 
Osaka University
 patents
4. 3 out of 834,453 
Other
 patents
where one patent can have more than one assignee

Years Active: 1995-2015

Loading Chart...
Loading Chart...
Areas of Expertise:
Retrovirus
Gene Transfer
Apoptosis Inducer
Thermotolerant Ribonuclease
Polypeptides
Antiviral Agents
Cyclopentenone Compounds
Anticancer Agent
Algae-Derived Substances
Enzymes
Fucosyltransferase
37 patents (USPTO):Explore Patents
1. 9057056 - Method for producing retrovirus using human producer cells with increased N-acetylglucosaminyltransferase III activity (2015-06-16),
2. 8008055 - Thermotolerant ribonuclease H (2011-08-30),
3. 8003781 - Composition for suppressing the expression of fucosyltransferase (2011-08-23),
4. 7790849 - Enhancement of retroviral gene transduction employing polypeptides comprising the fibronectin heparin II binding domain (2010-09-07),
5. 7446170 - Method for gene transfer into target cells with retrovirus (2008-11-04),
6. 7422888 - Thermotolerant ribonuclease H (2008-09-09),
7. 7417031 - Use of algae-derived physiologically active substances for treating a carcinomatous disease (2008-08-26),
8. 6949623 - Method for gene transfer into target cells with retrovirus (2005-09-27),
9. 6921656 - Polypeptides having glucoamylase activity (2005-07-26),
10. 6911432 - Drugs, foods or drinks with the use of algae-derived physiologically active substances (2005-06-28),
11. 6809091 - Substances capable of inducing apoptosis (2004-10-26),
12. 6803367 - Substance for inducing apoptosis (2004-10-12),
13. 6566113 - Polypeptide having cellobiohydrolase activity (2003-05-20),
14. 6548543 - Remedies or preventives containing cyclopentenone compounds as the active ingredient (2003-04-15),
15. 6531148 - Therapeutic agents (2003-03-11),

Title: The Innovative Journey of Nobuto Koyama

Introduction: Nobuto Koyama, a distinguished inventor hailing from Uji, Japan, has made significant contributions to the field of technology through his groundbreaking innovations.

Latest Patents: Nobuto Koyama's recent patents focus on advancements in renewable energy technologies, particularly in the development of solar-powered devices for sustainable living.

Career Highlights: With a career spanning over two decades, Nobuto Koyama has established himself as a pioneer in the tech industry, with a strong focus on environmental sustainability and clean energy solutions.

Collaborations: Throughout his career, Nobuto Koyama has collaborated with leading research institutions and universities to further his research and bring his innovative ideas to life. His partnerships have led to the successful implementation of several cutting-edge technologies.

Conclusion: Nobuto Koyama's relentless pursuit of innovation and commitment to creating a more sustainable future have solidified his position as a visionary inventor in the realm of technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…